Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 Mg) for the Treatment of Rosacea
Journey Medical公司宣佈Emrosi™(米諾環素鹽酸鹽緩釋膠囊,40毫克)獲得美國FDA批准,用於治療酒渣鼻
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 Mg) for the Treatment of Rosacea
Journey Medical公司宣佈Emrosi™(米諾環素鹽酸鹽緩釋膠囊,40毫克)獲得美國FDA批准,用於治療酒渣鼻
譯文內容由第三人軟體翻譯。